BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 4082237)

  • 1. New and simple method to predict dosage of drugs obeying simple Michaelis-Menten elimination kinetics and to distinguish such kinetics from simple first order and from parallel Michaelis-Menten and first order kinetics.
    Wagner JG
    Ther Drug Monit; 1985; 7(4):377-86. PubMed ID: 4082237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.
    Wagner JG; Szpunar GJ; Ferry JJ
    Biopharm Drug Dispos; 1985; 6(2):177-200. PubMed ID: 4005396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of a new and simple technique for individualizing phenytoin dosage.
    Yukawa E; Higuchi S; Aoyama T
    J Pharmacobiodyn; 1989 Apr; 12(4):187-92. PubMed ID: 2795428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol: pooled Michaelis-Menten parameters and the effect of input rate on bioavailability.
    Wagner JG
    Clin Pharmacol Ther; 1985 May; 37(5):481-7. PubMed ID: 3987171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a programmable calculator to determine steady-state levels of drugs eliminated by parallel first-order and Michaelis-Menten kinetics.
    Crow JW; Levy G
    Am J Hosp Pharm; 1978 Sep; 35(9):1075-7. PubMed ID: 696752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to reach steady state and prediction of steady-state concentrations for drugs obeying Michaelis-Menten elimination kinetics.
    Wagner JG
    J Pharmacokinet Biopharm; 1978 Jun; 6(3):209-25. PubMed ID: 671227
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative evaluation of six techniques for determining the Michaelis-Menten parameters relating phenytoin dose and steady-state serum concentrations.
    Mullen PW; Foster RW
    J Pharm Pharmacol; 1979 Feb; 31(2):100-4. PubMed ID: 33239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-pass effect: nonlinear concept comprising an explicit solution of integrated Michaelis-Menten equation.
    Keller F; Scholle J
    J Pharm Sci; 1981 Feb; 70(2):195-8. PubMed ID: 7205226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated equation to evaluate accumulation profiles of drugs eliminated by Michaelis-Menten kinetics.
    Lam G; Chiou WL
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):227-32. PubMed ID: 20218016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation: II. Michaelis-Menten kinetics.
    Gonda I
    J Pharmacokinet Biopharm; 1984 Oct; 12(5):525-34. PubMed ID: 6520746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steady-state characteristics and optimal dosage regimens for Michaelis-Menten elimination drugs].
    Liu D; Li J; Liu X
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Mar; 26(1):61-5. PubMed ID: 7657342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steady-state plasma concentrations as a function of the absorption rate and dosing interval for drugs exhibiting concentration-dependent clearance: consequences for phenytoin therapy.
    Sawchuk RJ; Rector TS
    J Pharmacokinet Biopharm; 1979 Dec; 7(6):543-55. PubMed ID: 529023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Michaelis-Menten metabolite formation kinetics: equations relating area under the curve and metabolite recovery to the administered dose.
    Chow AT; Jusko WJ
    J Pharm Sci; 1990 Oct; 79(10):902-6. PubMed ID: 2280360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mathematical study on characteristics of the average steady-state for drugs obeying Michaelis-Menten elimination kinetics].
    Zhou HW
    Zhongguo Yao Li Xue Bao; 1986 Sep; 7(5):385-9. PubMed ID: 2954407
    [No Abstract]   [Full Text] [Related]  

  • 15. Computational problems of compartment models with Michaelis-Menten-type elimination.
    Metzler CM; Tong DD
    J Pharm Sci; 1981 Jul; 70(7):733-7. PubMed ID: 7264916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin pharmacokinetic analysis and steady-state level prediction using a programmable calculator.
    Ng PK
    Int J Biomed Comput; 1980 Jul; 11(4):329-034. PubMed ID: 7399737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.
    Popović J
    Eur J Drug Metab Pharmacokinet; 2004; 29(3):205-14. PubMed ID: 15537173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shortcut formulae for pharmacokinetic dosage adjustments.
    Belloto RJ
    Clin Pharmacokinet; 2009; 48(9):555-60. PubMed ID: 19725590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closed form solutions and dominant elimination pathways of simultaneous first-order and Michaelis-Menten kinetics.
    Wu X; Li J; Nekka F
    J Pharmacokinet Pharmacodyn; 2015 Apr; 42(2):151-61. PubMed ID: 25678215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.